efegatran has been researched along with Angina at Rest in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karsch, KR; Oberhoff, M | 1 |
| Boersma, H; Deckers, JW; Klootwijk, P; Lenderink, T; Meij, S; Melkert, R; Müller, EJ; Poortermans, KJ; Simoons, ML; Stibbe, J; Umans, VA | 1 |
1 review(s) available for efegatran and Angina at Rest
| Article | Year |
|---|---|
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Topics: Angina, Unstable; Antithrombins; Arginine; Glycine; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Oligopeptides; Peptide Fragments; Pipecolic Acids; Piperidines; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Survival Rate; Thrombin | 2002 |
1 trial(s) available for efegatran and Angina at Rest
| Article | Year |
|---|---|
Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.
Topics: Adult; Aged; Angina, Unstable; Anticoagulants; Antithrombins; Dose-Response Relationship, Drug; Electrocardiography; Female; Heparin; Humans; Male; Middle Aged; Monitoring, Ambulatory; Oligopeptides; Partial Thromboplastin Time; Single-Blind Method; Treatment Outcome | 1999 |
1 other study(ies) available for efegatran and Angina at Rest
| Article | Year |
|---|---|
Synthetic direct thrombin inhibitors in unstable angina - more questions than answers.
Topics: Angina, Unstable; Anticoagulants; Antithrombins; Hirudin Therapy; Humans; Oligopeptides; Treatment Outcome | 1999 |